Trajan Group Holdings Ltd
ASX:TRJ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Trajan Group Holdings Ltd
Revenue
Trajan Group Holdings Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Trajan Group Holdings Ltd
ASX:TRJ
|
Revenue
AU$166.5m
|
CAGR 3-Years
16%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Genetic Technologies Ltd
ASX:GTG
|
Revenue
AU$3.7m
|
CAGR 3-Years
20%
|
CAGR 5-Years
245%
|
CAGR 10-Years
0%
|
|
|
Anteotech Ltd
ASX:ADO
|
Revenue
AU$445.5k
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-7%
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Revenue
AU$3.2m
|
CAGR 3-Years
20%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Cryosite Ltd
ASX:CTE
|
Revenue
AU$15.7m
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
5%
|
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Revenue
AU$66.9m
|
CAGR 3-Years
65%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Trajan Group Holdings Ltd
Glance View
Trajan Group Holdings Ltd. engages in the designing, manufacturing and supply of products and solutions that enhance scientific measurement. The firm is developing and manufacturing analytical science instruments, devices and solutions used in the analysis of biological, food and environmental samples. The firm is focused on serving life science, biopharmaceutical, and analytical companies in the United States, Australia, Europe, and Asia. The firm is operating in two segments, which includes Analytical Products and Life Science Solutions. Its Analytical Products include Metal syringes, Gas tight syringes, eVol, liquid extraction (uLLE), Electrokinetic extraction (EkE), Ferrules, Microfluidics, Emitter tips, Septa and caps and Porous polymer monoliths. Its Life Science Solutions include Dispensing syringes, Microscope slides, Coverslips, Slide and cassette storage, Liquid powder dispensing, Infusion automation, hemaPEN, Microbiopsy and Hummingbird. The company also offers micro-biopsy device for skin sampling, including Mitra device.
See Also
What is Trajan Group Holdings Ltd's Revenue?
Revenue
166.5m
AUD
Based on the financial report for Jun 30, 2025, Trajan Group Holdings Ltd's Revenue amounts to 166.5m AUD.
What is Trajan Group Holdings Ltd's Revenue growth rate?
Revenue CAGR 5Y
18%
Over the last year, the Revenue growth was 7%. The average annual Revenue growth rates for Trajan Group Holdings Ltd have been 16% over the past three years , 18% over the past five years .
